Literature DB >> 18632822

Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF.

Zhongli Cai1, Zhuo Chen, Kristy E Bailey, Deborah A Scollard, Raymond M Reilly, Katherine A Vallis.   

Abstract

UNLABELLED: The Auger electron-emitting radiopharmaceutical 111In-diethylenetriaminepentaacetic acid human epidermal growth factor (111In-DTPA-hEGF) binds the epidermal growth factor receptor (EGFR), is internalized, and translocates to the nucleus. The purpose of this study was to investigate the relationship between EGFR expression, DNA damage, and cytotoxicity in cells exposed to 111In-DTPA-hEGF.
METHODS: Breast cancer cell lines with a range of EGFR expression levels were exposed to 111In-DTPA-hEGF or gamma-radiation. The cell lines (followed by number of EGFR per cell in parentheses) were MDA-MB-468 (1.3 x 10(6)), MDA-MB-231 (1.3 x 10(5)), and MCF-7 (1.5 x 10(4)). The proportion of radioactivity partitioning into the nucleus was measured by cell fractionation. DNA double-strand breaks were evaluated using the gamma-H2AX assay. Clonogenic survival assays were used to measure cytotoxicity.
RESULTS: All data are presented as mean +/- SD. The amount of 111In-DTPA-hEGF that translocated to the nucleus (in mBq/nucleus) in MDA-MB-468, MDA-MB-231, and MCF-7 cells incubated with 111In-DTPA-hEGF (5.2 MBq/mL, 43 nM) for 20 h was 131 +/- 6, 8.1 +/- 0.1, and 1.1 +/- 0.9, respectively. The number of gamma-H2AX foci per nucleus was 35 +/- 15, 19 +/- 10, and 1.7 +/- 0.3, respectively. A reduction in the surviving fraction (SF) in MDA-MB-468 (0.013 +/- 0.001) and MDA-MB-231 (0.5 +/- 0.1) but not in MCF-7 cells after exposure to 111In-DTPA-hEGF (5.2 MBq/mL, 43 nM) for 20 h has been demonstrated. The SF of MDA-MB-468 cells after exposure to DTPA-EGF (43 nM) and 111In-acetate (5.2 MBq/mL) for 20 h was 0.5 +/- 0.1 and 0.53 +/- 0.05, respectively. MDA-MB-468 was the most sensitive of the cell lines to gamma-irradiation, with an SF after 2 Gy of 0.45 +/- 0.04, compared with 0.7 +/- 0.1 and 0.8 +/- 0.1 for MCF-7 and MDA-MB-231, respectively. The number of gamma-H2AX foci per nucleus in MDA-MB-468 cells correlated with the concentration, specific activity, and incubation time of 111In-DTPA-hEGF.
CONCLUSION: DNA damage caused by 111In-DTPA-hEGF correlates with the EGFR expression level of the exposed cells and with concentration, specific activity, and incubation time of 111In-DTPA-hEGF. The gamma-H2AX assay may be a useful biomarker to predict and monitor the outcome of treatment with 111In-DTPA-hEGF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632822     DOI: 10.2967/jnumed.108.051805

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

1.  Graphene nanoribbons elicit cell specific uptake and delivery via activation of epidermal growth factor receptor enhanced by human papillomavirus E5 protein.

Authors:  Sayan Mullick Chowdhury; Prady Manepalli; Balaji Sitharaman
Journal:  Acta Biomater       Date:  2014-06-27       Impact factor: 8.947

2.  Effects of Breast Shielding during Heart Imaging on DNA Double-Strand-Break Levels: A Prospective Randomized Controlled Trial.

Authors:  Michael K Cheezum; Christophe E Redon; Allison S Burrell; Anthony S Kaviratne; Jody Bindeman; Daisuke Maeda; Houria Balmakhtar; Ashly Pezel; Piotr Wisniewski; Panfilo Delacruz; Binh Nguyen; William M Bonner; Todd C Villines
Journal:  Radiology       Date:  2016-04-15       Impact factor: 11.105

3.  Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.

Authors:  Katherine A Vallis; Raymond M Reilly; Deborah Scollard; Pat Merante; Anthony Brade; Sobi Velauthapillai; Curtis Caldwell; Ida Chan; Marc Freeman; Gina Lockwood; Naomi A Miller; Bart Cornelissen; Jennifer Petronis; Kathryn Sabate
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

4.  Trastuzumab labeled to high specific activity with ¹¹¹In by conjugation to G4 PAMAM dendrimers derivatized with multiple DTPA chelators exhibits increased cytotoxic potency on HER2-positive breast cancer cells.

Authors:  Conrad Chan; Zhongli Cai; Raymond M Reilly
Journal:  Pharm Res       Date:  2013-04-25       Impact factor: 4.200

5.  Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy.

Authors:  Samantha Y A Terry; Katherine A Vallis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-14       Impact factor: 7.038

6.  Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells.

Authors:  Lihua H Wang; Thomas D Pfister; Ralph E Parchment; Shivaani Kummar; Larry Rubinstein; Yvonne A Evrard; Martin E Gutierrez; Anthony J Murgo; Joseph E Tomaszewski; James H Doroshow; Robert J Kinders
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

7.  Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.

Authors:  Bart Cornelissen; Veerle Kersemans; Sonali Darbar; James Thompson; Ketan Shah; Kate Sleeth; Mark A Hill; Katherine A Vallis
Journal:  Cancer Res       Date:  2011-05-17       Impact factor: 12.701

8.  Evaluation of Acridine Orange Derivatives as DNA-Targeted Radiopharmaceuticals for Auger Therapy: Influence of the Radionuclide and Distance to DNA.

Authors:  Edgar Pereira; Letícia do Quental; Elisa Palma; Maria Cristina Oliveira; Filipa Mendes; Paula Raposinho; Isabel Correia; João Lavrado; Salvatore Di Maria; Ana Belchior; Pedro Vaz; Isabel Santos; António Paulo
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

9.  111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells.

Authors:  Martin R Gill; Jyothi U Menon; Paul J Jarman; Joshua Owen; Irini Skaripa-Koukelli; Sarah Able; Jim A Thomas; Robert Carlisle; Katherine A Vallis
Journal:  Nanoscale       Date:  2018-06-07       Impact factor: 8.307

10.  Radiobiological Characterization of 64CuCl₂ as a Simple Tool for Prostate Cancer Theranostics.

Authors:  Joana Fernandes Guerreiro; Vítor Alves; Antero José Abrunhosa; António Paulo; Octávia Monteiro Gil; Filipa Mendes
Journal:  Molecules       Date:  2018-11-11       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.